Business Context and Reporting Period
This Form 8-K Current Report was filed by U.S. Bancorp on October 26, 2020, with the earliest event reported on that date and the transaction closing on October 27, 2020. The filing primarily addresses a material modification to the rights of security holders and the completion of a preferred stock offering.
Key Financial Metrics and Transaction Details
The filing details a capital raise transaction rather than periodic operating results. Key metrics include:
- Transaction Type: Sale of 20,000,000 Depositary Shares.
- Underlying Security: Series L Non-Cumulative Perpetual Preferred Stock.
- Conversion Ratio: Each Depositary Share represents a 1/1,000th interest in a share of Preferred Stock.
- Liquidation Preference: $25,000 per share of Preferred Stock.
- Underwriters: Morgan Stanley & Co. LLC, U.S. Bancorp Investments, Inc., BofA Securities, Inc., RBC Capital Markets, LLC, UBS Securities LLC, and Wells Fargo Securities, LLC.
Note: The filing text does not provide specific values for total proceeds, revenue, profit, cash flow, margins, or debt levels.
Material Changes
The primary material change reported is the amendment to the Company's Certificate of Incorporation to fix the designations, preferences, limitations, and relative rights of the new Series L Preferred Stock. Additionally, the Company closed the sale of the aforementioned depositary shares, increasing its capital base.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific risk factors beyond the standard legal disclosures associated with the issuance of preferred stock. The transaction was registered pursuant to a Form S-3 registration statement that became automatically effective on March 11, 2020.
Investor Verification Checklist
- Verify the total gross proceeds from the sale of the 20,000,000 Depositary Shares in the accompanying press release or Form 424B2.
- Review the specific dividend rate and payment frequency for the Series L Preferred Stock in the Certificate of Designations (Exhibit 4.1).
- Confirm the impact of this issuance on the company's overall capital structure and regulatory capital ratios.
- Check for any underwriting discounts or commissions that may affect net proceeds.